The cardioprotectant 3′,4′-dihydroxyflavonol inhibits opening of the mitochondrial permeability transition pore after myocardial ischemia and reperfusion in rats-Reference-Cited by-同舟云学术

The cardioprotectant 3′,4′-dihydroxyflavonol inhibits opening of the mitochondrial permeability transition pore after myocardial ischemia and reperfusion in rats

Published:2014-03 Issue: Volume:81 Page:26-33
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Woodman O.L.,Long R.,Pons S.,Eychenne N.,Berdeaux A.,Morin D.

Funder

Universite Paris Est

Ministere de la Recherche et de la Technologie

Publisher

Elsevier BV

Subject

Pharmacology

Reference36 articles.

1. Myocardial reperfusion injury;Yellon;N Engl J Med,2007

2. Mitochondria and reperfusion injury of the heart – a holey death but not beyond salvation;Halestrap;J Bioeng Biomembr,2009

3. Mitochondrial pathways, permeability transition pore, and redox signaling in cardioprotection: therapeutic implications;Penna;Antiox Redox Signal,2013

4. Mitochondrial permeability transition pore opening during myocardial reperfusion – a target for cardioprotection;Halestrap;Cardiovasc Res,2004

5. Mitochondria as a drug target in ischemic heart disease and cardiomyopathy;Walters;Circ Res,2012

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improvement of neuronal and cognitive functions following treatment with 3′,4′ dihydroxyflavonol in experimental focal cerebral ischemia-reperfusion injury in rats;European Journal of Pharmacology;2024-08

2. The New Nano-Resuscitation Solution (TPP-MR) Attenuated Myocardial Injury in Hemorrhagic Shock Rats by Inhibiting Ferroptosis;International Journal of Nanomedicine;2024-07

3. Cardiolipin in myocardial ischaemia-reperfusion injury: From molecular mechanisms to clinical strategies;Biomedicine & Pharmacotherapy;2024-07

4. Effects of Malate Ringer's solution on myocardial injury in sepsis and enforcement effects of TPP@PAMAM-MR;Journal of Translational Medicine;2022-12-13

5. VX-765 prevents intestinal ischemia-reperfusion injury by inhibiting NLRP3 inflammasome;Tissue and Cell;2022-04